IN2014KN02722A - - Google Patents

Info

Publication number
IN2014KN02722A
IN2014KN02722A IN2722KON2014A IN2014KN02722A IN 2014KN02722 A IN2014KN02722 A IN 2014KN02722A IN 2722KON2014 A IN2722KON2014 A IN 2722KON2014A IN 2014KN02722 A IN2014KN02722 A IN 2014KN02722A
Authority
IN
India
Prior art keywords
purification
preparation
processes
efficient
high quality
Prior art date
Application number
Other languages
English (en)
Inventor
Wayne D Luke
Steffen Jost
Original Assignee
Phosplatin Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phosplatin Therapeutics Llc filed Critical Phosplatin Therapeutics Llc
Publication of IN2014KN02722A publication Critical patent/IN2014KN02722A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN2722KON2014 2012-05-24 2013-03-15 IN2014KN02722A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261651200P 2012-05-24 2012-05-24
PCT/US2013/031885 WO2013176764A1 (en) 2012-05-24 2013-03-15 Synthetic and purification methods for phosphaplatin compounds and uses thereof

Publications (1)

Publication Number Publication Date
IN2014KN02722A true IN2014KN02722A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2015-05-08

Family

ID=49624225

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2722KON2014 IN2014KN02722A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2012-05-24 2013-03-15

Country Status (18)

Country Link
US (2) US8846964B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (2) EP3202769B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP5833795B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (2) CN106967124B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY (2) CY1118746T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (2) DK2855496T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (2) ES2619412T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HR (2) HRP20170416T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (2) HUE032197T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN2014KN02722A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LT (2) LT3202769T (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (2) PL2855496T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (2) PT3202769T (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RS (2) RS59725B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SI (2) SI3202769T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SM (2) SMT201700168T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (2) TWI599361B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2013176764A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013176764A1 (en) * 2012-05-24 2013-11-28 Phosplatin Therapeutics Llc Synthetic and purification methods for phosphaplatin compounds and uses thereof
CN109310663B (zh) * 2016-04-06 2022-05-31 弗斯普拉廷治疗有限公司 磷铂液体制剂
US10668080B2 (en) 2017-01-06 2020-06-02 Phosplatin Therapeutics Llc Phosphaplatin compounds as therapeutic agents for treatment of bone or blood cancers
EP3679046B1 (en) * 2017-09-08 2023-11-08 Promontory Therapeutics Inc. Phosphaplatin compounds as immuno-modulatory agents and therapeutic uses thereof
CN113861036B (zh) * 2021-11-08 2024-04-02 合肥工业大学 一种乙二胺高氯酸铜配合物的制备及用途
US11673904B1 (en) 2021-12-09 2023-06-13 L'air Liquide, Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Low pressure process for synthesis of Pt(PF3)4 involving a soluble intermediate and storage of obtained Pt(PF3)4
CN119822568B (zh) * 2025-02-19 2025-08-19 扬州宏鑫环保科技有限公司 一种高效纯化水制备装置及制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234500A (en) * 1979-03-07 1980-11-18 Engelhard Minerals & Chemicals Corporation Ethylenediamine platinum(II) and 1,2-diamino-cyclohexane platinum(II) pyrophosphate complexes
CA2530279A1 (en) 2003-06-27 2005-01-06 Akira Odani Bisphosphonate complexes
JP2009525273A (ja) * 2006-01-30 2009-07-09 プラットコー テクノロジーズ (プロプライエタリー) リミテッド 白金(ii)錯体の調製
JP5489988B2 (ja) * 2007-05-18 2014-05-14 Tti・エルビュー株式会社 有効成分の生体界面への改善された放出を確保する経皮送達装置
CN101801369B (zh) 2007-08-06 2012-09-19 俄亥俄大学 磷铂及其在治疗顺铂和卡铂耐药性癌中的用途
EP2575802B1 (en) * 2010-06-04 2016-11-16 Ohio University Phosphaplatins and their use for treatment of cancers
US9012669B2 (en) * 2011-10-05 2015-04-21 The University Of Houston System Efficient processes for large scale preparation of phosphaplatins antitumor agents
WO2013176764A1 (en) * 2012-05-24 2013-11-28 Phosplatin Therapeutics Llc Synthetic and purification methods for phosphaplatin compounds and uses thereof

Also Published As

Publication number Publication date
PL3202769T3 (pl) 2020-03-31
DK3202769T3 (da) 2019-10-28
RS55806B1 (sr) 2017-08-31
US8859796B1 (en) 2014-10-14
PL2855496T3 (pl) 2017-09-29
DK2855496T3 (en) 2017-03-27
EP3202769B1 (en) 2019-10-02
HUE046327T2 (hu) 2020-03-30
TWI653237B (zh) 2019-03-11
HRP20191904T1 (hr) 2020-01-24
HUE032197T2 (en) 2017-09-28
SI3202769T1 (sl) 2020-02-28
RS59725B1 (sr) 2020-01-31
HK1203202A1 (en) 2015-10-23
TW201741326A (zh) 2017-12-01
SMT201700168T1 (it) 2017-05-08
PT2855496T (pt) 2017-03-23
CY1118746T1 (el) 2018-03-07
CY1122316T1 (el) 2021-01-27
WO2013176764A1 (en) 2013-11-28
US20140024848A1 (en) 2014-01-23
US20140288321A1 (en) 2014-09-25
JP2015523335A (ja) 2015-08-13
LT3202769T (lt) 2019-12-10
SMT201900617T1 (it) 2020-01-14
CN104540839A (zh) 2015-04-22
ES2751668T3 (es) 2020-04-01
CN106967124A (zh) 2017-07-21
US8846964B2 (en) 2014-09-30
EP2855496B1 (en) 2016-12-14
ES2619412T3 (es) 2017-06-26
CN106967124B (zh) 2020-03-06
SI2855496T1 (sl) 2017-04-26
JP5833795B2 (ja) 2015-12-16
EP3202769A1 (en) 2017-08-09
PT3202769T (pt) 2019-10-31
EP2855496A4 (en) 2015-04-08
TW201347765A (zh) 2013-12-01
CN104540839B (zh) 2017-02-22
HRP20170416T1 (hr) 2017-05-19
EP2855496A1 (en) 2015-04-08
TWI599361B (zh) 2017-09-21
LT2855496T (lt) 2017-04-10

Similar Documents

Publication Publication Date Title
IN2015KN00262A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SG10201900948PA (en) Modified nucleotide linkers
EA201492165A1 (ru) Синтез пирроло[2,3-b]пиридинов
IN2014KN02722A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX2016012419A (es) Formas solidas de ibrutinib y procesos para la produccion de las mismas.
MX2013005549A (es) Aminas heterociclicas y sus usos.
EP2687510A4 (en) PROCESS FOR THE PREPARATION OF 2,3-DICHLORPYRIDINE
EA201790916A1 (ru) Новые лиганды rig-i и способы их получения
IN2014DN09085A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH12015500376B1 (en) Novel bicyclic pyridinones
IN2012MU03723A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO2014178078A3 (en) Novel cloning, expression & purification method for the preparation of ranibizumab
IN2015KN00323A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY194466A (en) Heterophasic polypropylene composition
EP2738153A4 (en) PROCESS FOR PREPARING 3,3-DIMETHYL-BUTYRALDEHYDE
GEP201706626B (en) Synthesis of (s)-nifuratel
EP2937326A4 (en) PREPARATION PROCESS FOR 1,3, 3,3-TETRAFLUORPROPEN
EP2759529A4 (en) PROCESS FOR PREPARING 1-PALMITOYL-3-ACETYLGLYCEROL AND PROCESS FOR PREPARING 1-PALMITOYL-2-LINOLEOYL-3-ACETYLGLYCEROL THEREWITH
EP2930166A4 (en) PROCESS FOR THE PREPARATION OF 3-AMINOMETHYL-3,5,5-TRIMETHYLCYCLOHEXYLAMINE
EP2936998A4 (en) TTEOK COMPOSITION WITH TAGATOSE, TTEOK AND MANUFACTURING METHOD THEREFOR
EP2987854A4 (en) MICROORGANISM WITH L-TRYPTOPHANE PRODUCTIVITY AND METHOD FOR THE PRODUCTION OF L-TRYPTOPHANE THEREWITH
MX2013013436A (es) Derivados de indol sustituidos para el tratamiento de transtornos inmunologicos.
IN2013CH04906A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB201107985D0 (en) Process
PH12014501367A1 (en) Processes for making magnolol and derivatives thereof